MVision AI Appoints Antti Pirskanen as New Chief Financial Officer

Helsinki, Finland – June 14, 2024 – MVision AI, a pioneering company in the development of innovative AI solutions for radiation oncology is pleased to announce the appointment of Antti Pirskanen as its new Chief Financial Officer (CFO). Antti will assume his responsibilities immediately, bringing extensive expertise in financial management and strategic growth to the company.

Antti Pirskanen joins MVision AI from Newil & Bau, where he served as CFO. During his tenure, he successfully navigated challenging market conditions, leading capital raisings and various business development projects. Antti’s distinguished career also includes an important role at Vaaka Partners, Finland’s leading private equity firm, where he drove substantial investments and played a key role in portfolio management and growth strategies.

Antti holds a Master of Science in Economics from the Helsinki School of Economics, with a major in Finance. His robust background in private equity, buyout investments and financial analysis makes him an invaluable addition to the MVision AI team.

“We are excited to welcome Antti Pirskanen to MVision AI,” said Dharanipathy Rangaraj, CEO of MVision AI. “Antti’s extensive experience and proven track record in financial leadership will be crucial as we continue to expand and innovate in the AI healthcare industry. His strategic vision and operational expertise will drive our financial strategy forward, supporting our mission to revolutionize healthcare through advanced AI solutions.”

Antti Pirskanen expressed his enthusiasm about joining MVision AI: “I am looking forward to joining MVision AI at such a pivotal time in the company’s growth. I look forward to working with the talented team at MVision AI to build on the company’s successes and contribute to its future achievements.”

For more information about MVision AI and its innovative solutions, visit www.mvision.ai.

Media Contact:

Sakthy Edamaruku

Communication Specialist

MVision AI

info@mvision.ai

About MVision AI

MVision AI is your trusted partner in healthcare innovation! MVision AI is an innovative software service provider for radiotherapy treatment planning and Imaging. Our AI-powered automatic segmentation tool, Contour+, helps to standardize contouring and automate segmentation to streamline the radiotherapy treatment planning workflow. We are a team of experienced professionals committed to revolutionizing the cancer care industry through the application of cutting-edge AI technology. At MVision AI, we understand the challenges faced by healthcare providers in delivering accurate, timely, and efficient cancer care to patients. That’s why we are developing a suite of AI-powered solutions that can help streamline radiation therapy workflows, enable treatment quality and lead to standardization.

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

2.7.2024

Breaking New Ground: MVision AI Contour+ for Upright MRI Scans

Results on testing MVision AI Contour+ for an ingenious and modern approach in radiation therapy have been recently presented at the 62nd Particle Therapy Co-Operative Group (PTCOG) conference in Singapore. Despite being trained using supine MR data and a different magnetic strength from different scanners, authors reported that MVision AI's…

Articles

28.6.2024

AI Role in Improving Contouring Skills of Radiation Oncologists—Results From a Large International Project

Many regions of the globe face significant disparities between the need of radiation therapy and its availability [1]. Another challenge is providing adequate training for radiation oncology professionals [2]. The cancer burden is expected to rise everywhere, especially the low- and middle-income countries [3]. Artificial intelligence offers a wide range…

Articles

20.6.2024

World Kidney Cancer Day 2024: “Listen”

World Kidney Cancer Day is observed every year on the second Thursday of June. “Listening” is this year’s theme, which refers to the benefits of shared decision making, patient’s empowerment to seek a second opinion and creating awareness around misinformation and how to check if sources are reliable (1). More…

News